Chemists Determine 1 Way Tumors Meet Their Growing Needs
8/27/2012
Behaving something like ravenous monsters, tumors need plentiful supplies of cellular building blocks such as amino acids and nucleotides in order to keep growing at a rapid pace and survive under harsh conditions. How such tumors meet these burgeoning demands has not been fully understood...
Viral Paths Toward Cancer Charted By Field Guide To The Epstein-Barr Virus
8/27/2012
Researchers from The Wistar Institute and Memorial Sloan-Kettering Cancer Center (MSKCC) have teamed to publish the first annotated atlas of the Epstein-Barr virus genome, creating the most comprehensive study of how the viral genome interacts with its human host during a latent infection...
News From The Journals Of The American Society For Microbiology: August 2012
8/26/2012
Boost for Efforts to Prevent Microbial Stowaways on Interplanetary Spacecraft Efforts to expunge micro-organisms from spacecraft assembly cleanrooms, and the spacecraft themselves, inadvertently select for the organisms that are often the most fit to survive long journeys in space...
Scientists In Germany Study Cancer Survival After The Fall Of The Iron Curtain
8/26/2012
Data from the 1970s and 1980s show that people affected by cancer survived significantly longer in West Germany than cancer patients behind the Iron Curtain...
Why Humans May Be More Susceptible To Cancer And Other Diseases
8/26/2012
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role...
Cancer Prevention, Treatment By Targeting Inflammation
8/25/2012
Researchers at the Georgia Health Sciences University Cancer Center have identified a gene that disrupts the inflammatory process implicated in liver cancer. Laboratory mice bred without the gene lacked a pro-inflammatory protein called TREM-1 and protected them from developing liver cancer after exposure to carcinogens...
Pancreatic Cancer Patients' Choices Easier With New Study
8/24/2012
Almost 45,000 Americans are diagnosed with pancreatic cancer each year. No matter how the disease is treated, it almost always kills within two years after diagnosis, not leaving good odds for those diagnosed. Depending on the stage of the cancer, aggressive intervention with chemotherapy, surgery, or radiation may add an extra month to a year of survival, but unfortunately that is very rare...
PSA Testing For Screening Prostate Cancer Has Improved Survival Rates
8/24/2012
According to a new study published in The Journal of Urology, the introduction of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has improved survival rates for patients whose disease has metastasized to other areas of the body. In addition, PSA testing has resolved the disparity between African American and Caucasian men. Lead researcher Ian M...
Unique Adverse Events With Newly Approved Drug Reviewed By Melanoma Expert
8/24/2012
An internationally recognized melanoma researcher at Moffitt Cancer Center and colleagues at the University of Kiel in Germany, including Axel Hauschild, M.D., and Katharina C. Kahler, M.D., have published an article in the Journal of Clinical Oncology that describes immune-related adverse events for patients receiving either tremelimumab or ipilimumab...
Intravenous Administration Of Green Tea Compound Shows Promise For Tackling Cancer
8/24/2012
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland. The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumours when delivered by conventional intravenous administration...